Structural basis for inhibition of the Tob-CNOT7 interaction by a fragment screening approach

References

[1] Doidge R, Mittal S, Aslam A, Winkler GS (2012) The anti-proliferative activity of BTG/TOB proteins is mediated via the Caf1a (CNOT7) and Caf1b (CNOT8) deadenylase subunits of the Ccr4-not complex. PLoS One 7:e51331

[2] Ezzeddine N, Chang TC, Zhu W, Yamashita A, Chen CY, Zhong Z, Yamashita Y, Zheng D, Shyu AB (2007) Human TOB, an antiproliferative transcription factor, is a poly(A)-binding proteindependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27:7791–7801

[3] Ezzeddine N, Chen CY, Shyu AB (2012) Evidence providing new insights into TOB-promoted deadenylation and supporting a link between TOB's deadenylation-enhancing and antiproliferative activities. Mol Cell Biol 32:1089–1098

[4] Giannetti AM, Koch BD, Browner MF (2008) Surface plasmon resonance based assay for the detection and characterization of promiscuous inhibitors. J Med Chem 51:574–580

[5] Hann MM, Leach AR, Harper G (2001) Molecular complexity and its impact on the probability of finding leads for drug discovery. J Chem Inf Comput Sci 41:856–864

[6] Horiuchi M, Takeuchi K, Noda N, Muroya N, Suzuki T, Nakamura T, Kawamura-Tsuzuku J, Takahasi K, Yamamoto T, Inagaki F (2009) Structural basis for the antiproliferative activity of the Tob-hCaf1 complex. J Biol Chem 284:13244–13255

[7] Ito Y, Suzuki T, Yoshida H, Tomoda C, Uruno T, Takamura Y, Miya A, Kobayashi K, Matsuzuka F, Kuma K (2005) Phosphorylation and inactivation of Tob contributes to the progression of papillary carcinoma of the thyroid. Cancer Lett 220:237–242

[8] Iwanaga K, Sueoka N, Sato A, Sakuragi T, Sakao Y, Tominaga M, Suzuki T, Yoshida Y, Tsuzuku KT, Yamamoto T (2003) Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202:71–79

[9] Jia S, Meng A (2007) Tob genes in development and homeostasis. Dev Dyn 236:913–921

[10] Matsuda S, Rouault J, Magaud J, Berthet C (2001) In search of a function for the TIS21/PC3/BTG1/TOB family. FEBS Lett 497:67–72

[11] Mauxion F, Chen CY, Seraphin B, Shyu AB (2009) BTG/TOB factors impact deadenylases. Trends Biochem Sci 34:640–647

[12] Pfaff SJ, Chimenti MS, Kelly MJ, Arkin MR (2015) Biophysical methods for identifying fragment-based inhibitors of proteinprotein interactions. Methods Mol Biol 1278:587–613

[13] Suzuki T, Tsuzuku J, Hayashi A, Shiomi Y, Iwanari H, Mochizuki Y, Hamakubo T, Kodama T, Nishitani H, Masai H (2012) Inhibition of DNA damage-induced apoptosis through Cdc7-mediated stabilization of Tob. J Biol Chem 287:40256–40265

[14] Winkler GS (2010) The mammalian anti-proliferative BTG/Tob protein family. J Cell Physiol 222:66–72

[15] Yang X, Morita M, Wang H, Suzuki T, Yang W, Luo Y, Zhao C, Yu Y, Bartlam M, Yamamoto T (2008) Crystal structures of human BTG2 and mouse TIS21 involved in suppression of CAF1deadenylase activity. Nucleic Acids Res 36:6872–6881

RIGHTS & PERMISSIONS

2014 This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.